• Merger Hamlet-SelectImmune
  • hamletpharma.com
  • selectimmune.com
    • Årsredovisningar
      • 20/21
      • 21/22
      • 22/23
Hamlet BioPharma
  • News
    • Press releases
    • Newsletters
    • Media Archive
    • Subscribe
    • Series of digital events
    • Commercial collaborations
  • Drug Development
    • Cancer
    • Infections
    • Tuberculosis
    • Our Pipeline
    • Publications
  • Contact us
  • Hamlet Biopharma
    • Patents
    • Board & Executive Team
  • Finance and Investor Relations
    • Financial Reports
    • Financial Calendar
    • General Meetings
    • The share
    • Spotlight Stock Market
    • Prospectus 2024
Press enter to begin your search

hbp-logo

An innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections.

Hamlet Biopharma AB
Klinikgatan 32
SE-222 42 Lund
info@hamletbiopharma.com
Org. no. 556568-8958

Subscribe to receive newsletters

© 2025 Hamlet BioPharma.

  • News
    • Press releases
    • Newsletters
    • Media Archive
    • Subscribe
    • Series of digital events
    • Commercial collaborations
  • Drug Development
    • Cancer
    • Infections
    • Tuberculosis
    • Our Pipeline
    • Publications
  • Contact us
  • Hamlet Biopharma
    • Patents
    • Board & Executive Team
  • Finance and Investor Relations
    • Financial Reports
    • Financial Calendar
    • General Meetings
    • The share
    • Spotlight Stock Market
    • Prospectus 2024
  • Merger Hamlet-SelectImmune
  • hamletpharma.com
  • selectimmune.com
    • Årsredovisningar
      • 20/21
      • 21/22
      • 22/23

Hamlet Pharma AB

BMC D10
Klinikgatan 32
SE-222 42 Lund, Sweden
+46 40 12 25 00
info@hamletpharma.com

Swedish